Home
Conditions
Hemostatic Disorders

Clinical trial condition

Hemostatic Disorders

Explore clinical trials studying Hemostatic Disorders. Study availability and eligibility vary by location and protocol.

3,080 public trials 582 recruiting studies

Refine in advanced search Browse all conditions

Hemostatic Disorders trial results

Completed

Chemotherapy Followed by Allogeneic Stem Cell Transplantation for Hematologic Malignancies

NCT00741455

Conditions: Blood Protein Disorders, Bone Marrow Diseases, Cardiovascular Diseases, +34 more
Locations: Dartmouth-Hitchcock Medical Center Lebanon, New Hampshire, United States

View Trial Details

Completed

Prospective Descriptive Study of the Angiogenic T Cell Population in Subjects With Hereditary Hemorrhagic Telangiectasia (HHT)

NCT03572556

Conditions: Cardiovascular Abnormalities, Cardiovascular Diseases, Congenital Abnormalities, +10 more
Locations: CHU Dijon Bourgogne Dijon, France

View Trial Details

Completed

"WB-DCE-MRI" in Multiple Myeloma as an Independent Prognostic Factor for Disease-free Survival

NCT01171430

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Henri Mondor Hospital Créteil, France

View Trial Details

Completed

Vorinostat (MK-0683, SAHA [Suberoylanilide Hydroxamic Acid]) + Lenalidomide + Dexamethasone in Multiple Myeloma (MM) (MK-0683-074)

NCT00642954

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
Locations: Not specified

View Trial Details

Completed

Dose Escalation Study of JNJ-54767414 (Daratumumab) in Chinese Participants With Relapsed or Refractory Multiple Myeloma Who Failed at Least 2 Prior Lines of Systemic Therapy

NCT02852837

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Beijing, China

Hangzhou, China

Shanghai, China

Suzhou, China

View Trial Details

Completed

Low-Dose Azacitidine, Lenalidomide, and Low-Dose Dexamethasone in Relapsed or Refractory Multiple Myeloma

NCT01155583

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States

Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States

View Trial Details

Completed

Prevalence, Intensity and Consequences of Bortezomib-induced Neuropathic Disorders.

NCT03344328

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Chemotherapy Induced Peripheral Neuropathy, +13 more
Locations: CHU Clermont-Ferrand Clermont-Ferrand, France

View Trial Details

Completed

Aplidin - Dexamethasone in Relapsed/Refractory Myeloma

NCT01102426

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: 1107 Tuscaloosa, Alabama, United States

1103 Los Angeles, California, United States

1105 Jacksonville, Florida, United States

1102 New York, United States

View all 82 locations

View Trial Details

Completed

Phase 1b Study of Weekly Carfilzomib in Combination With Lenalidomide and Dexamethasone in Subjects With Multiple Myeloma

NCT02335983

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Research Site Bakersfield, California, United States

CBCC Global Research, Inc. at Comprehensive Blood and Cancer Center Bakersfield, California, United States

Research Site Burbank, California, United States

Providence Saint Joseph Medical Center Burbank, California, United States

View all 59 locations

View Trial Details

Completed

Rehabilitation Needs of the Malaysian Haematological Cancer Survivors

NCT04236063

Conditions: Blood Cancer, Blood Protein Disorders, Cardiovascular Diseases, +22 more
Locations: University Malaya Kuala Lumpur, Malaysia

View Trial Details

Hemostatic Disorders

Hemostatic Disorders trial results

Related conditions